{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:14:05Z","timestamp":1790172845081,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/BIO\/04469\/2013"],"award-info":[{"award-number":["UID\/BIO\/04469\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jconrel.2016.05.064","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T02:37:57Z","timestamp":1464748677000},"page":"112-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment"],"prefix":"10.1016","volume":"235","author":[{"given":"Jo\u00e3o P.","family":"Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Silva-Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ant\u00f3nio G.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Pedrosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Appelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Miguel","family":"Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.05.064_bb0005","series-title":"Global Tuberculosis Report","author":"World Health Organization (WHO)","year":"2015"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0010","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(15)00458-0","article-title":"Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis","volume":"3","author":"Kendall","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)00151-8","article-title":"Tuberculosis","author":"Dheda","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1385\/IR:35:3:179","article-title":"Pathogenesis of Mycobacterium avium infection: typical responses to an atypical mycobacterium?","volume":"35","author":"Appelberg","year":"2006","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0025","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nrmicro2437","article-title":"Nanobead-based interventions for the treatment and prevention of tuberculosis","volume":"8","author":"Griffiths","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0030","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1073\/pnas.0737613100","article-title":"Mycobacterium tuberculosis glycosylated phosphatidylinositol causes phagosome maturation arrest","volume":"100","author":"Fratti","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0035","article-title":"Inhaled drug treatment for tuberculosis: past progress and future prospects","author":"Hickey","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0040","doi-asserted-by":"crossref","first-page":"g4643","DOI":"10.1136\/bmj.g4643","article-title":"Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis","volume":"349","author":"Roy","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1473-3099(14)70885-0","article-title":"Shortening treatment of tuberculosis: lessons from fluoroquinolone trials","volume":"15","author":"Nimmo","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0050","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(04)15496-2","article-title":"Programmes and principles in treatment of multidrug-resistant tuberculosis","volume":"363","author":"Mukherjee","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0055","series-title":"MSF Access Campaign: DR-TB Drugs under the Microscope \u2014 Sources and Prices for Drug-Resistant Tuberculosis Medicines","author":"M\u00e9decins sans Fronti\u00e8res (MSF)","year":"2012"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0060","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.addr.2009.11.023","article-title":"New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery","volume":"62","author":"Sosnik","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nrd4001","article-title":"Advances in the development of new tuberculosis drugs and treatment regimens","volume":"12","author":"Zumla","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0070","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1183\/09031936.00113713","article-title":"Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis","volume":"43","author":"Alsaad","year":"2014","journal-title":"Eur. Resp. J."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0075","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/nm.3937","article-title":"The association between sterilizing activity and drug distribution into tuberculosis lesions","volume":"21","author":"Prideaux","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0080","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.biomaterials.2013.11.035","article-title":"Anti-mycobacterial activities of synthetic cationic \u03b1-helical peptides and their synergism with rifampicin","volume":"35","author":"Khara","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.tube.2014.03.011","article-title":"Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects","volume":"94","author":"Padhi","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0090","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0095","first-page":"11","article-title":"Antimicrobial peptides in human skin disease","volume":"18","author":"Yamasaki","year":"2008","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0100","first-page":"11","article-title":"Antimicrobial peptide resistance mechanisms of human bacterial pathogens","volume":"8","author":"Nizet","year":"2006","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0105","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrmicro1441","article-title":"The co-evolution of host cationic antimicrobial peptides and microbial resistance","volume":"4","author":"Peschel","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0110","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/IAI.01218-07","article-title":"Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells","volume":"76","author":"Rivas-Santiago","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2466-13-23","article-title":"Oral intake of phenylbutyrate with or without vitamin d-3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis","volume":"13","author":"Mily","year":"2013","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0120","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1128\/AAC.49.7.2845-2850.2005","article-title":"Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37","volume":"49","author":"Ciornei","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00011-004-1323-8","article-title":"Augmentation of the bactericidal activities of human cathelicidin cap18\/ll-37-derived antimicrobial peptides by amino acid substitutions","volume":"54","author":"Nagaoka","year":"2005","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0130","first-page":"1","article-title":"Endogenous cathelicidin production limits inflammation and protective immunity to mycobacterium avium in mice","volume":"2","author":"Santos","year":"2014","journal-title":"Immunol. Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0135","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/156802608783955629","article-title":"Developments on drug delivery systems for the treatment of mycobacterial infections","volume":"8","author":"Gaspar","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0140","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jconrel.2010.11.024","article-title":"Designing carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide","volume":"150","author":"Bi","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0145","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/mabi.201400135","article-title":"A novel crosslinked hyaluronic acid nanogel for drug delivery","volume":"14","author":"Pedrosa","year":"2014","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.rvsc.2008.07.016","article-title":"Expression of macrophage CD44 receptor in the course of experimental inflammatory response of bovine mammary gland induced by lipopolysaccharide and muramyl dipeptide","volume":"86","author":"Sladek","year":"2009","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0155","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/dbio.1993.1032","article-title":"CD44 positive macrophages take up hyaluronan during lung development","volume":"155","author":"Underhill","year":"1993","journal-title":"Dev. Biol."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(90)90267-D","article-title":"Zero-length crosslinking procedure with the use of active esters","volume":"185","author":"Grabarek","year":"1990","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0165","first-page":"311","article-title":"A simple ultraviolet spectrophotometric method for the determination of protein","volume":"48","author":"Waddell","year":"1956","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0170","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4049\/jimmunol.0902717","article-title":"IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone","volume":"184","author":"Torrado","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/10715760701787719","article-title":"Protective role of new nitrogen compounds on ROS\/RNS-mediated damage to PC12 cells","volume":"42","author":"Silva","year":"2008","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jchromb.2006.07.054","article-title":"Analysis of nitrite and nitrate in biological fluids by assays based on the griess reaction: appraisal of the griess reaction in the l-arginine\/nitric oxide area of research","volume":"851","author":"Tsikas","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0185","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/mpat.1996.0106","article-title":"Expression of the green fluorescent protein (GFP) in Mycobacterium avium as a tool to study the interaction between mycobacteria and host cells","volume":"22","author":"Parker","year":"1997","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0190","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/eji.200737954","article-title":"Engagement of toll-like receptor 2 in mouse macrophages infected with mycobacterium avium induces non-oxidative and tnf-independent anti-mycobacterial activity","volume":"38","author":"Gomes","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0195","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nprot.2006.30","article-title":"A direct approach to quantification of the cellular uptake of cell-penetrating peptides using maldi-tof mass spectrometry","volume":"1","author":"Burlina","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0200","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1084\/jem.20100265","article-title":"Pathological role of interleukin 17 in mice subjected to repeated bcg vaccination after infection with Mycobacterium tuberculosis","volume":"207","author":"Cruz","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0205","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/AAC.00595-10","article-title":"Comparative studies evaluating mouse models used for efficacy testing of experimental drugs against Mycobacterium tuberculosis","volume":"55","author":"De Groote","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0210","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2005.04.009","article-title":"Non-invasive pulmonary aerosol delivery in mice by the endotracheal route","volume":"61","author":"Bivas-Benita","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0215","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1128\/AAC.02475-12","article-title":"Cationic antimicrobial peptides and biogenic silver nanoparticles kill mycobacteria without eliciting DNA damage and cytotoxicity in mouse macrophages","volume":"57","author":"Mohanty","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0220","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0225","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1096\/fj.01-0295com","article-title":"Protein tyrosine nitration in mouse peritoneal macrophages activated in vitro and in vivo: evidence against an essential role of peroxynitrite","volume":"15","author":"Pfeiffer","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0230","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1128\/AAC.40.8.1759","article-title":"Susceptibility testing of mycobacterium avium complex isolates","volume":"40","author":"Heifets","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0235","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1128\/AAC.04841-14","article-title":"Characterization of mouse models of Mycobacterium avium complex infection and evaluation of drug combinations","volume":"59","author":"Andrejak","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0240","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1086\/587906","article-title":"The efficacy of clarithromycin and the bicyclolide EDP-420 against Mycobacterium avium in a mouse model of pulmonary infection","volume":"197","author":"Bermudez","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0245","doi-asserted-by":"crossref","first-page":"8028","DOI":"10.4049\/jimmunol.178.12.8028","article-title":"IL-10 underlies distinct susceptibility of balb\/c and C57BL\/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy","volume":"178","author":"Roque","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0250","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.actbio.2015.07.043","article-title":"Improved burn wound healing by the antimicrobial peptide LLKKK18 released from conjugates with dextrin embedded in a carbopol gel","volume":"26","author":"Silva","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0255","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.peptides.2012.04.018","article-title":"Effect of antimicrobial peptides on atpase activity and proton pumping in plasma membrane vesicles obtained from mycobacteria","volume":"36","author":"Santos","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050345","article-title":"Azurophil granule proteins constitute the major mycobactericidal proteins in human neutrophils and enhance the killing of mycobacteria in macrophages","volume":"7","author":"Jena","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0265","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jac\/dkt322","article-title":"De novo generation of short antimicrobial peptides with enhanced stability and cell specificity","volume":"69","author":"Kim","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0270","first-page":"613","article-title":"Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles","volume":"61","author":"Kumar","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0275","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jac\/dki027","article-title":"Antitubercular inhaled therapy: opportunities, progress and challenges","volume":"55","author":"Pandey","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0280","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11095-008-9562-y","article-title":"Role of particle size in phagocytosis of polymeric microspheres","volume":"25","author":"Champion","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0285","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1039\/c0nr00478b","article-title":"Surface charge of gold nanoparticles mediates mechanism of toxicity","volume":"3","author":"Schaeublin","year":"2011","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0290","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3109\/08923973.2011.565345","article-title":"Effect of anionic and cationic n-butylcyanoacrylate nanoparticles on NO and cytokine production in RAW264.7 cells, Immunopharm","volume":"33","author":"Tomita","year":"2011","journal-title":"Immunotoxicology"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0295","first-page":"972","article-title":"Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18\/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues","volume":"9","author":"Nagaoka","year":"2002","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0300","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/AAC.01533-06","article-title":"Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin","volume":"51","author":"Gumbo","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0305","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1164\/ajrccm\/138.4.999","article-title":"Minimal inhibitory concentrations of isoniazid, rifampin, ethambutol, and streptomycin against Mycobacterium tuberculosis strains isolated before treatment of patients in Taiwan","volume":"138","author":"Suo","year":"1988","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0310","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1186\/2193-1801-2-686","article-title":"Interleukin-6: a potent biomarker of mycobacterial infection","volume":"2","author":"Singh","year":"2013","journal-title":"Springerplus"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0315","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1128\/IAI.00936-15","article-title":"Ll-37 immunomodulatory activity during Mycobacterium tuberculosis infection in macrophages","volume":"83","author":"Torres-Juarez","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0320","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/infdis\/jit037","article-title":"Role of interleukin 6 in innate immunity to mycobacterium tuberculosis infection","volume":"207","author":"Martinez","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0325","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/187152809787582543","article-title":"TNF-alpha in tuberculosis: a cytokine with a split personality","volume":"8","author":"Mootoo","year":"2009","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.jconrel.2016.05.064_bb0330","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1084\/jem.104.5.763","article-title":"The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug","volume":"104","author":"McCune","year":"1956","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0335","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/82142","article-title":"In vivo veritas: the search for TB drug targets goes live","volume":"6","author":"McKinney","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0340","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/IAI.67.7.3610-3618.1999","article-title":"Resistance of virulent Mycobacterium avium to gamma interferon-mediated antimicrobial activity suggests additional signals for induction of mycobacteriostasis","volume":"67","author":"Fl\u00f3rido","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0345","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.4049\/jimmunol.1201525","article-title":"Molecular and cellular mechanisms of Mycobacterium avium-induced thymic atrophy","volume":"189","author":"Borges","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0350","first-page":"857","article-title":"Treatment of tuberculosis: present status and future prospects","volume":"83","author":"Onyebujoh","year":"2005","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0355","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI200316936","article-title":"CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis","volume":"111","author":"Leemans","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0360","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1128\/IAI.71.7.4102-4111.2003","article-title":"CD44-regulated intracellular proliferation of Listeria monocytogenes","volume":"71","author":"Eriksson","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jconrel.2016.05.064_bb0365","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1086\/424463","article-title":"Role of human neutrophil peptide-1 as a possible adjunct to antituberculosis chemotherapy","volume":"190","author":"Kalita","year":"2004","journal-title":"J. Infect. Dis."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916303546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916303546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:36:47Z","timestamp":1785775007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916303546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":73,"alternative-id":["S0168365916303546"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.064","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.05.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}